Hydroxycarbamide (Hydrea, Siklos, Xromi)

Hydroxycarbamide, also known as hydroxyurea, is a medication primarily used to manage sickle cell disease by reducing the frequency of painful crises and the need for blood transfusions.

About hydroxycarbamide tablets and oral solution

Hydroxycarbamide is available under brand names such as

Hydrea

(capsules),

Siklos

(dissolvable tablets), and

Xromi

(oral solution). These formulations treat sickle cell disease, a genetic condition where red blood cells become rigid and sickle-shaped, leading to blocked blood vessels and complications like pain crises and acute chest syndrome. Hydrea has been authorized for decades, primarily for cancer, while Siklos and Xromi are tailored for sickle cell anemia in pediatric and adult patients.

The oral solution form, like Xromi, offers precise dosing for children as young as 6-9 months, making it easier to administer than capsules. Siklos provides dissolvable tablets for accurate weight-based dosing.

Key facts

• Hydroxycarbamide increases fetal hemoglobin, making red blood cells more flexible and less likely to sickle.
• Treatment typically lasts long-term, often lifelong for sickle cell management.
• Common side effects include lowered blood cell counts, nausea, and skin changes.
• Requires regular blood tests to monitor safety.
• Not suitable during pregnancy due to risk of birth defects.

When to take hydroxycarbamide

Hydroxycarbamide is taken

once daily

, preferably at the same time each day, with or without food. For liquid forms like Xromi, use the provided syringe for accurate measurement. Swallow Siklos tablets whole or dissolve in water; do not chew. Consistency is crucial for maintaining steady drug levels to prevent crises.

How to take hydroxycarbamide

Follow your doctor’s instructions precisely. Capsules (Hydrea) should be swallowed whole. For Siklos, dissolve in a small amount of water if needed. Shake Xromi oral solution well before use. If you miss a dose, take it as soon as remembered unless close to the next dose—do not double up.

Dosing Forms Comparison

Brand	Form	Age Group	Typical Starting Dose
Hydrea	Capsule	Adults/Children	15-20 mg/kg/day
Siklos	Dissolvable Tablet	≥2 years	15-20 mg/kg/day
Xromi	Oral Solution	≥6-9 months	15 mg/kg/day

Common questions about how to take hydroxycarbamide

How long does hydroxycarbamide take to work?

Benefits may appear within 6-12 months, with reduced crises noted after consistent use. Full effects on hemoglobin can take up to a year.

Can you take hydroxycarbamide on an empty stomach?

Yes, but taking with food may reduce nausea.

Can you take other medicines with hydroxycarbamide?

Inform your doctor about all medications, as it may interact with blood thinners, vaccines, or other myelosuppressants.

Dosage

Dosage is weight-based, starting at 15-20 mg/kg/day for sickle cell disease, adjusted every 8 weeks based on blood counts and response. Maximum is around 35 mg/kg/day. Children under 9 months require specialist oversight.

Sickle Cell Disease Dosing Guidelines

Patient Group	Initial Dose	Adjustment	Max Dose
Pediatric (Xromi/Siklos)	15 mg/kg/day	Increase 5 mg/kg every 8 weeks	35 mg/kg/day
Adults (Hydrea)	15-20 mg/kg/day	Based on counts	35 mg/kg/day

Further information

Always store at room temperature, away from moisture. Dispose of unused medication properly. Regular follow-ups are essential.

How does hydroxycarbamide work?

Hydroxycarbamide inhibits DNA synthesis, reducing abnormal sickle cells and boosting fetal hemoglobin, which prevents sickling and vaso-occlusion. This lowers crisis frequency and transfusion needs.

When is hydroxycarbamide prescribed?

Prescribed for sickle cell anemia patients with recurrent moderate-to-severe painful crises, from 6-9 months onward depending on formulation. Also used off-label for certain cancers like CML.

When is hydroxycarbamide not suitable?

• Pregnancy or breastfeeding
• Severe bone marrow suppression
• Known hypersensitivity
• Uncontrolled infections

Sickle cell disease management

In sickle cell disease, hydroxycarbamide prevents vaso-occlusive events, stroke risk, and acute chest syndrome by improving red cell flexibility and reducing adhesion.

Side effects

Monitor for myelosuppression (low white cells, anemia, platelets). Other effects: nausea, skin ulcers, hair loss, fertility issues.

Side Effects Overview

Common	Serious
Nausea, diarrhea, rash	Bone marrow suppression, infections, leg ulcers
Hair thinning	Secondary cancers (rare)

Cautions

• Regular blood monitoring mandatory
• Avoid live vaccines
• Use contraception; men for 6-12 months post-treatment
• Sun protection due to skin sensitivity

Interactions

• Other myelotoxic drugs
• Antiretrovirals
• Live vaccines

Other medicines, food and drink

No major food interactions, but avoid excessive alcohol. Inform doctor of all supplements.

Pregnancy and fertility

Contraindicated in pregnancy (category D); causes fetal harm. Effective contraception required. May impair male fertility.

Breastfeeding

Not recommended; drug passes into milk.

Having an operation

Inform surgeon; may need dose adjustment.

Alcohol

Limited alcohol; may worsen side effects.

Frequently Asked Questions (FAQs)

Q: Who can take Xromi?

A: Pediatric patients 6 months and older with sickle cell anemia and recurrent crises.

Q: How often are blood tests needed?

A: Before starting and every 2-4 weeks initially, then monthly.

Q: Does hydroxycarbamide cure sickle cell disease?

A: No, it manages symptoms and reduces complications.

Q: Can adults use Siklos?

A: Yes, approved for adults and children ≥2 years.

Q: What if blood counts drop?

A: Dose reduction or interruption; recovery is usually rapid.